Cardiff Oncology Inc
Statements
Cash Flow
Cardiff Oncology Inc (CRDF) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -12 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.0 | -9.0 | -8.8 | -4.6 | -6.6 | -3.3 | -2.9 | -3.3 | -3.5 | -3.6 | -3.4 | -3.4 | -3.2 | -3.3 | -3.4 | -4.3 | -3.5 | -5.1 | -5.9 | -4.3 | -5.5 | -7.4 | -10 | -6.7 | -7.5 | -9.4 | -8.7 | -7.1 | -8.0 | -7.1 | -7.7 | -9.2 | -10 | -10 | -13 | -8.3 | -11 | -6.0 | -12 | -12 | -41 | |
| 0.2 | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.0 | 0.0 | 0.0 | 0.4 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.5 | 0.2 | 0.2 | 0.0 | 0.9 | |
| 1.8 | 1.6 | 0.9 | 0.8 | 1.4 | 0.9 | 1.4 | 0.2 | 0.3 | 0.3 | 0.2 | 0.1 | 0.3 | 0.3 | 0.2 | 0.3 | 0.4 | 0.9 | 0.3 | 1.0 | 0.9 | 1.0 | 1.2 | 1.1 | 1.0 | 1.0 | 1.1 | 1.6 | 1.0 | 0.9 | 1.1 | 1.2 | 1.3 | 1.2 | 1.4 | 1.7 | 1.4 | 1.3 | 1.7 | 0.9 | 5.2 | |
| – | – | 0.9 | 2.5 | -0.1 | – | 1.5 | -0.1 | 0.3 | 0.4 | 0.2 | 0.1 | 0.5 | 0.3 | 0.2 | 0.6 | 0.9 | 1.1 | 0.1 | 2.0 | 0.9 | 1.0 | 1.6 | 1.3 | 1.2 | 1.0 | 1.1 | 1.6 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 1.0 | -1.3 | -0.2 | 0.7 | -2.4 | -1.2 | 0.2 | 0.5 | -0.1 | -0.3 | 0.2 | 0.3 | 0.5 | 0.1 | 0.1 | -0.9 | 0.0 | 0.1 | -1.5 | 0.3 | -0.6 | 0.0 | -0.9 | 2.4 | -0.1 | -1.8 | 1.6 | 2.6 | 1.0 | 1.4 | 1.2 | 1.4 | 0.2 | 0.4 | -0.8 | 4.0 | -1.2 | -0.1 | -1.7 | -3.6 | -6.6 | |
| 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.2 | 0.3 | 0.4 | 0.1 | 0.0 | 0.3 | 0.3 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| 3.4 | 0.4 | 5.2 | 19 | -0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 23 | 0.0 | -0.1 | -0.1 | -68 | -0.2 | -0.2 | -0.2 | -0.1 | -112 | -19 | 8.0 | -8.8 | 18 | 7.6 | 5.2 | 7.0 | 7.3 | 11 | 3.8 | 14 | 4.6 | 14 | -9.4 | 4.5 | -15 | -5.0 | 10 | 11 | 3.3 | 12 | 36 | |
| – | 24 | 0.0 | – | – | 24 | 0.0 | – | – | 24 | 0.0 | – | – | 24 | 0.0 | – | 0.0 | – | 0.0 | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 | – | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | – | – | – | – | – | – | – | – | |
| – | 24 | – | 0.1 | 6.5 | 24 | 1.4 | 16 | – | 13,114 | 3.3 | 2.9 | 1.5 | 4.4 | 2.5 | 22 | 12 | 100 | 1.3 | 19 | – | 15 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -0.2 | -17 | -0.2 | – | -0.2 | -1.2 | – | – | – | – | 0.3 | 0.3 | 0.3 | 0.3 | -0.3 | -0.3 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 3.7 | -0.1 | -0.2 | -17 | 6.4 | 4.1 | 1.3 | 15 | – | 16,387 | 3.2 | 2.9 | 1.5 | 4.4 | 2.5 | 23 | 12 | 100 | 1.3 | 19 | 15 | 15 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 2.1 | 7.4 | 44 | 0.0 | 0.0 | 0.0 | 2.6 | 0.1 | 0.1 | 2.8 | |
| 0.0 | -8.7 | -3.7 | -2.4 | -0.3 | 0.8 | -1.6 | 12 | -3.4 | -3.6 | -0.1 | -0.5 | -1.8 | 1.2 | -0.9 | 18 | 8.7 | 95 | -116 | -4.1 | 2.6 | -1.2 | 8.1 | 0.9 | -2.2 | -2.4 | -1.3 | 4.4 | -4.1 | 6.4 | -3.0 | 6.8 | -12 | 38 | -27 | -13 | -0.6 | 7.3 | -8.9 | 0.7 | -1.6 | |
| -7.2 | -9.0 | -8.8 | -4.6 | -6.7 | -3.2 | -2.9 | -3.3 | -3.5 | -3.6 | -3.4 | -3.4 | -3.2 | -3.2 | -3.4 | -4.3 | -3.7 | -5.2 | -5.9 | -4.3 | -5.6 | -7.5 | -10 | -7.0 | -7.9 | -9.5 | -8.7 | -7.4 | -8.3 | -7.1 | -7.8 | -9.2 | -10 | -10 | -13 | -8.4 | -11 | -6.0 | -12 | -12 | -41 |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.